Cargando…
Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein
BACKGROUND: Doxorubicin (DOX) is a potent chemotherapeutic agent used to treat colon cancer. Despite impressive initial clinical responses, drug resistance has dramatically compromised the effectiveness of DOX. However, the underlying mechanisms of chemotherapeutic resistance in colon cancer remain...
Autores principales: | Wang, Huaiming, Deng, Zhenwei, Chen, Xinhua, Cai, Jian, Ma, Tenghui, Zhong, Qinghua, Li, Ruiping, Li, Libo, Lin, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442496/ https://www.ncbi.nlm.nih.gov/pubmed/30904920 http://dx.doi.org/10.12659/MSM.913325 |
Ejemplares similares
-
Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901
por: Deng, Zhenwei, et al.
Publicado: (2019) -
MicroRNA-328-3p Protects Vascular Endothelial Cells Against Oxidized Low-Density Lipoprotein Induced Injury via Targeting Forkhead Box Protein O4 (FOXO4) in Atherosclerosis
por: Qin, Xiaowei, et al.
Publicado: (2020) -
Laminarin-induced apoptosis in human colon cancer LoVo cells
por: JI, CHEN-FENG, et al.
Publicado: (2014) -
Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of β-Catenin in SW620 Cells
por: Liu, Kuiliang, et al.
Publicado: (2017) -
Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin
por: Castiglioni, Sara, et al.
Publicado: (2015)